Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

IGC Pharma (IGC) Shares Issued (2016 - 2025)

IGC Pharma has reported Shares Issued over the past 15 years, most recently at $3.1 million for Q3 2025.

Quarterly Shares Issued rose 291.32% to $3.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Sep 2025, up 47.38% year-over-year, with the annual reading at $4.5 million for FY2025, 47.14% up from the prior year.
Shares Issued was $3.1 million for Q3 2025 at IGC Pharma, up from $852000.0 in the prior quarter.
Over five years, Shares Issued peaked at $14.2 million in Q1 2021 and troughed at -$103000.0 in Q1 2023.
The 5-year median for Shares Issued is $805000.0 (2025), against an average of $2.3 million.
Year-over-year, Shares Issued soared 78755.56% in 2021 and then crashed 96.99% in 2022.
A 5-year view of Shares Issued shows it stood at $3.4 million in 2021, then crashed by 96.99% to $103000.0 in 2022, then skyrocketed by 2676.7% to $2.9 million in 2023, then plummeted by 87.9% to $346000.0 in 2024, then skyrocketed by 799.13% to $3.1 million in 2025.
Per Business Quant, the three most recent readings for IGC's Shares Issued are $3.1 million (Q3 2025), $852000.0 (Q2 2025), and $805000.0 (Q1 2025).